- Home
- NGS vs XBIT Comparison
NGS vs XBIT Comparison
Compare NGS & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NGS
- XBIT
- Stock Information
- Founded
- NGS 1998
- XBIT 2005
- Country
- NGS United States
- XBIT United States
- Employees
- NGS N/A
- XBIT N/A
- Industry
- NGS Oilfield Services/Equipment
- XBIT Pharmaceuticals and Biotechnology
- Sector
- NGS Energy
- XBIT Health Care
- Exchange
- NGS Nasdaq
- XBIT Nasdaq
- Market Cap
- NGS 241.7M
- XBIT 194.5M
- IPO Year
- NGS 2002
- XBIT 2015
- Fundamental
- Price
- NGS $27.99
- XBIT $3.82
- Analyst Decision
- NGS Strong Buy
- XBIT
- Analyst Count
- NGS 2
- XBIT 0
- Target Price
- NGS $26.50
- XBIT N/A
- AVG Volume (30 Days)
- NGS 83.5K
- XBIT 94.1K
- Earning Date
- NGS 11-14-2024
- XBIT 11-13-2024
- Dividend Yield
- NGS N/A
- XBIT N/A
- EPS Growth
- NGS 605.21
- XBIT N/A
- EPS
- NGS 1.28
- XBIT N/A
- Revenue
- NGS $152,305,000.00
- XBIT N/A
- Revenue This Year
- NGS $30.81
- XBIT N/A
- Revenue Next Year
- NGS $13.48
- XBIT N/A
- P/E Ratio
- NGS $21.84
- XBIT N/A
- Revenue Growth
- NGS 41.72
- XBIT N/A
- 52 Week Low
- NGS $14.09
- XBIT $3.51
- 52 Week High
- NGS $28.50
- XBIT $9.96
- Technical
- Relative Strength Index (RSI)
- NGS 60.61
- XBIT 32.16
- Support Level
- NGS $27.15
- XBIT $3.64
- Resistance Level
- NGS $28.40
- XBIT $4.00
- Average True Range (ATR)
- NGS 1.22
- XBIT 0.34
- MACD
- NGS 0.07
- XBIT 0.02
- Stochastic Oscillator
- NGS 87.31
- XBIT 17.48
About NGS Natural Gas Services Group Inc.
Natural Gas Services Group Inc provides natural gas compression equipment and services to the energy industry. The company manufactures, fabricates, rents, sells, and maintains natural gas compressors and flare systems for oil and natural gas production and plant facilities. Its operating units include Rental, Sales, and Aftermarket services. The company generates the majority of its revenue by renting out low- to medium-horsepower compression equipment to natural gas production companies in unconventional oil and gas regions of the United States.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.